検索結果

General Announcement: November 1, 2023 Senju Pharmaceutical Co., Ltd. Launch of Distribution of the OptiLight M22 IPL Model Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. S

E-commerce business | Business Activities | About Senju | SENJU Pharmaceutical

Wellness items that promote health every day to contribute to the health of all people. Senju Pharmaceutical, as a pioneer of ophthalmic drugs, has long engaged in developing prescription and OTC drug

Medical devices and healthcare | Business Activities | About Senju | SENJU Pharmaceutical

We will contribute to medical care and your health requirements in the new era through medical devices. Today, in the era of the 100-year-life, digital transformation is being promoted in various fiel

Senju initiated Phase III Clinical Trials in Japan for “SJP-0132” for the treatment of Dry Eye Disease The Clinical Trials use a novel compound discovered by Mochida and licensed to Senju Senju Pharma

NewMytear A | OTC Products, etc. | Products | SENJU Pharmaceutical

Category 3 OTC medicines New Mytear® A Supplies moisture. CHARACTERISTICS This is an artificial tear-type eye drop with mild sensation. It supplies the moisture of tears that is important to the eyes